Trials / Recruiting
RecruitingNCT06432894
Performance Evaluation of ANI in Patients Under General Anesthesia With Remimazolam
Performance Evaluation of Analgesia Nociception Index (ANI) in Patients Under General Anaesthesia With Remimazolam: a Prospective Observational Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Catholic Kwandong University · Academic / Other
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Analgesia Nociception Index (ANI) can effectively reduce the dose of opioid in patients who underwent general anesthesia using remimazolam.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Analgesia Nociception Index, remimazolam | The purpose of this study is to determine the validity of ANI in patients undergoing surgery with remifentanil and remimazolam. During this study, remimazolam infusion rate is determined by the pharmacopoeia. Remifentanil infusion rate is determined based on the patient's vital signs, systemic status and pain levels. And remifentanil is administrated via targeted infusion control using the Minto model. ANI scores, vital signs, remifentanil infusion rate are collected at predetermined time points according to the protocol from the start to the end of the surgery. |
Timeline
- Start date
- 2024-04-23
- Primary completion
- 2025-06-11
- Completion
- 2025-06-11
- First posted
- 2024-05-29
- Last updated
- 2024-05-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06432894. Inclusion in this directory is not an endorsement.